Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Potential new anticancer vaccines described

Oct. 21, 1997

Yale-Vion developing bacteria-based cancer treatment

Oct. 21, 1997

Peptech reaches phase I goals for antagonist G; exercises license option

Oct. 20, 1997

ImClone and CombiChem enter alliance for drug discovery in oncology

Oct. 20, 1997

Agouron to collaborate with U.K. organizations in search for anticancer drugs

Oct. 17, 1997

Health Research claims peptide inhibitor of growth factors

Oct. 17, 1997

S-1: pharmacokinetics of components in rats after single and multiple oral doses

Oct. 16, 1997

Nycomed licenses new anthracycline from Anthra

Oct. 16, 1997

UroCor to copromote Zeneca urology products

Oct. 16, 1997

Schering AG discloses improved taxanes

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...